Back to Journals » ImmunoTargets and Therapy » Volume 10 » default

ImmunoTargets and Therapy


Archive: Volume 10, 2021

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis

Atzeni F, Carriero A, Boccassini L, D'Angelo S

ImmunoTargets and Therapy 2021, 10:141-153

Published Date: 3 May 2021

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy

Xu N, Tse B, Yang L, Tang TCY, Haber M, Micklethwaite K, Dolnikov A

ImmunoTargets and Therapy 2021, 10:123-140

Published Date: 28 April 2021

TNFR2: Role in Cancer Immunology and Immunotherapy

Yang Y, Islam MS, Hu Y, Chen X

ImmunoTargets and Therapy 2021, 10:103-122

Published Date: 21 April 2021

Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches

Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F

ImmunoTargets and Therapy 2021, 10:63-85

Published Date: 9 March 2021

Soluble IL-7Rα/sCD127 in Health, Disease, and Its Potential Role as a Therapeutic Agent

Barros PO, Berthoud TK, Aloufi N, Angel JB

ImmunoTargets and Therapy 2021, 10:47-62

Published Date: 8 March 2021

Anti-IgE for the Treatment of Chronic Urticaria

Wedi B, Traidl S

ImmunoTargets and Therapy 2021, 10:27-45

Published Date: 17 February 2021

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

Passiglia F, Reale ML, Cetoretta V, Novello S

ImmunoTargets and Therapy 2021, 10:9-26

Published Date: 5 February 2021

Current Insights into Immunotherapy Approaches for Food Allergy

Macdougall JD, Burks AW, Kim EH

ImmunoTargets and Therapy 2021, 10:1-8

Published Date: 27 January 2021